SCHEMBL1665638

SCHEMBL1665638

COc1ccc(Cn2cnc3c(CO)cc(C)nc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ADORA2A P29274 1/20 0.47
HPGD P15428 1/20 0.46
CNR2 P34972 2/20 0.46
CTSL P07711 2/20 0.45
HSP90AA1 P07900 1/20 0.45
HSP90AB1 P08238 1/20 0.45
CCNE2 O96020 2/20 0.45
CCNE1 P24864 2/20 0.45
CDK2 P24941 2/20 0.45
YTHDC1 Q96MU7 3/20 0.45
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
NPY1R P25929 1/20 0.44
MET P08581 1/20 0.43
NR3C1 P04150 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667415 0.84 NR3C1 (0.46) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL1667447 0.81 HPGD (0.51) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL5140180 0.79 NR3C1 (0.46) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL5056015 0.76 CNR2 (0.45) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL14441143 0.76 MEN1 (0.52) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL14441142 0.75 HSP90AB1 (0.54) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL5133769 0.75 MEN1 (0.51) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL6948922 0.74 CNR2 (0.46) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL3821565 0.74 YTHDC1 (0.57) MEN1KMT2AL3MBTL1ADORA2AHPGD
SCHEMBL30834262 0.73 ADORA2A (0.49) MEN1KMT2AL3MBTL1ADORA2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891042-B1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA SA (BE) 2013-10-02 EP disclosed
EP-2308870-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed
EP-2308867-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed